A company has been fined for advertising the use of dietary supplements for treating cancer.

The limited liability company "Marva Hayat" has been fined 26 million sums for running an advertisement that claimed the dietary supplement "HALILA" could cure cancer. However, such information is not included in the product's instructions.

https://kun.uz/ru/news/2024/12/13/oshtrafovano-ooo-razmestivsheye-reklamu-o-lechenii-badom-onkologicheskix-zabolevaniy2024-12-14 08:51:12

LLC Marva Hayat has been fined for placing advertisements containing false information about the treatment of cancer with the dietary supplement (BAA) "HALILA." This was reported by the Antimonopoly Committee.

In its advertisements, LLC Marva Hayat claimed that the dietary supplement "HALILA" treats cancer, has been in use for 15 years, and that over 5000 individuals have been healed by it. However, according to the conclusion of the Committee for Sanitary and Epidemiological Welfare and Public Health, the information in the instruction for use of "HALILA" does not match the characteristics stated in the advertisements.

For violating legal requirements, the Antimonopoly Service imposed a fine on the company amounting to 70 basic calculated units (26.25 million sums). Additionally, the company has been ordered to compensate consumers for damages totaling 52.5 million sums.

This case underscores the importance of maintaining honesty and accuracy in advertising materials, especially regarding health-related products.